The Hospitalist Channel

Local Relapse Risk in Early Breast Cancer Increased with Anemia

:56 | Hospitalist, Internal Medicine, Ob/Gyn, Oncology, Oncology / Hematology, Pharmacists, Preventative Health, Women’s Health

A new analysis of data from a multicenter clinical trial suggests that chemotherapy-induced anemia significantly increases the risk of local relapse in premenopausal early-stage breast cancer.

References and Resources
Dubsky P, et al. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. Clin Cancer Res 2008; 14: 2082-2087.

More in Hospitalist

► 4:45

Will Current Approved Vaccines Be Effective Against Newer Coronavirus Strain?

COVID-19

In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University...

► 34:28

The Fink Tank: COVID-19 – Coronavirus Doesn’t Care Who You Voted For

COVID-19

Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center in LA,...

► 2:20

Healthcare Providers Are Not Immune to Mental Health Crises

COVID-19

Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal and/or family...

► 34:33

The Fink Tank: COVID-19 – Do Child Care Centers Pose A Spreading Risk?

COVID-19

Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center in LA,...